Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
196170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7196170005
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
- Website:
- http://www.alteogen.com/
Description
Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-11-17 00:00 |
기업설명회(IR)개최
|
Korean | 7.2 KB | ||
| 2021-11-15 00:00 |
분기보고서 (2021.09)
|
Korean | 1.5 MB | ||
| 2021-11-15 00:00 |
[기재정정]분기보고서 (2021.09)
|
Korean | 1.5 MB | ||
| 2021-10-25 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.4 KB | ||
| 2021-09-16 00:00 |
투자판단관련주요경영사항(ALT-BB4 (테르가제, 재조합 히알루로니다제)의 안전성과 내약성 및 약동학 특성을 평가하기 위한 임상시험 1상 계획…
|
Korean | 15.4 KB | ||
| 2021-09-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.7 KB | ||
| 2021-08-23 00:00 |
기업설명회(IR)개최
|
Korean | 7.5 KB | ||
| 2021-08-17 00:00 |
반기보고서 (2021.06)
|
Korean | 1.5 MB | ||
| 2021-08-10 00:00 |
[기재정정]사업보고서 (2020.12)
|
Korean | 1.7 MB | ||
| 2021-08-04 00:00 |
기타경영사항(자율공시)(아일리아 바이오시밀러 ALT-L9 국내 임상 1상 시험 결과)
|
Korean | 19.9 KB | ||
| 2021-08-03 00:00 |
투자판단관련주요경영사항(HER2 양성 유방암 대상자 중 표준 치료에 실패한 전이를 가진 진행성 또는 재발성 환자에게 ALT-P7을 주사제로 투…
|
Korean | 13.3 KB | ||
| 2021-07-06 00:00 |
기타경영사항(특허권취득)(자율공시)(FOLR1에 특이적으로 결합하는 항체 및 그의 용도)
|
Korean | 6.0 KB | ||
| 2021-05-17 00:00 |
분기보고서 (2021.03)
|
Korean | 1.6 MB | ||
| 2021-05-03 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.4 KB | ||
| 2021-04-06 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.8 KB |
Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alteogen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alteogen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
